Vitiligo has a strong genetic component, but it is not hereditary in the straightforward way that conditions like sickle cell disease are. You don’t inherit vitiligo itself. You inherit a collection of genetic variants that raise your risk of developing it. If one parent has vitiligo, a child’s chance of also developing it is roughly 5 to 6 percent, which means the vast majority of children with an affected parent never get the condition.
How Vitiligo Runs in Families
Vitiligo does not follow a simple one-gene inheritance pattern. Instead, it is polygenic, meaning dozens of genes each contribute a small amount of risk. Researchers have identified 50 different locations in the genome linked to vitiligo susceptibility, and these can be combined into what scientists call a “polygenic risk score.” The more risk variants you carry, the higher your overall likelihood. Families with multiple affected members tend to carry a greater total load of these risk variants than families where only one person is affected.
In rare cases, vitiligo can appear as part of a syndrome caused by a single, high-impact gene mutation. These conditions, which involve widespread autoimmune problems across multiple organs, are uncommon and look very different from typical vitiligo.
Twin Studies Show Genetics Isn’t Everything
One of the clearest ways to separate genetic influence from environmental influence is to study identical twins, who share 100% of their DNA. In vitiligo, the concordance rate in identical twins is only about 23%. That means when one twin has vitiligo, the other develops it less than a quarter of the time. This is strong evidence that while genetics loads the gun, something else pulls the trigger.
Environmental factors that can activate vitiligo in someone who is genetically predisposed include UV radiation exposure, chemical irritants, infections, and physical skin trauma. These stressors can alter how genes are expressed without changing the DNA itself, a process called epigenetic reprogramming. UV radiation, for example, can shift chemical tags on DNA in ways that disrupt normal pigment cell behavior and ramp up immune activity against those cells.
What the Key Genes Actually Do
About 85% of the genes linked to vitiligo are involved in immune system function and a form of cell death called apoptosis. This fits with what researchers understand about the condition: the immune system mistakenly attacks and destroys melanocytes, the cells that produce skin pigment. Three well-studied genes illustrate how this works.
One gene on chromosome 1 encodes a protein that acts as a brake on immune cells called T cells. A specific variant of this gene weakens that brake, allowing T cells to become overactive. This same variant also raises the risk of type 1 diabetes, rheumatoid arthritis, and lupus. A second gene on chromosome 17 is part of the body’s inflammation alarm system. Certain variants cause it to trigger inflammation more aggressively, releasing signals that can damage melanocytes. A third gene on chromosome 11 produces tyrosinase, the main enzyme melanocytes use to make pigment. The immune system in vitiligo patients often treats tyrosinase as a foreign invader. Variants in this gene appear to make the enzyme more recognizable to the immune system, essentially painting a target on melanocytes.
Vitiligo Clusters With Other Autoimmune Conditions
If you have vitiligo, you carry a genetically determined susceptibility not just to vitiligo but to a broader group of autoimmune diseases. Between 15% and 25% of people with generalized vitiligo have at least one additional autoimmune condition. Autoimmune thyroid disease is the most common, appearing in 17% to 25% of vitiligo patients. Other conditions that occur at elevated rates include rheumatoid arthritis, type 1 diabetes, pernicious anemia, psoriasis, Addison’s disease, and lupus.
This clustering extends beyond the patient. First-degree relatives of someone with vitiligo show higher rates of these same autoimmune diseases, even if they don’t have vitiligo themselves. The explanation is shared susceptibility genes: a core set of immune-related variants predisposes a family to autoimmune problems in general, while other genes and environmental exposures determine which specific disease, if any, shows up in each individual.
Family History and Earlier Onset
Having a family history of vitiligo doesn’t appear to make the disease more widespread or harder to treat, but it is linked to developing it earlier in life. Children with vitiligo who have relatives with the condition are nearly four times more likely to have an early age of onset compared to children with no family history. The distribution of patches, the specific body sites affected, and the overall course of the disease, however, show no meaningful differences based on family history.
Does Ethnicity Affect Genetic Risk?
Vitiligo occurs across all ethnic groups, with a global prevalence estimated between 0.2% and 0.8% depending on the population studied. UK data shows that Black, Asian, and mixed-ethnicity populations are represented among vitiligo patients at higher proportions than in the general population, aligning with previous reports that vitiligo prevalence is higher in people with darker skin tones. This doesn’t necessarily mean the underlying genetic risk is greater in these groups. Vitiligo is simply more visible and more likely to be diagnosed on darker skin, though genuine differences in genetic susceptibility across populations remain an active area of investigation. Most of the 50 known risk variants were identified through studies of people with European ancestry, so the full genetic picture in other populations is still incomplete.
Can Genetic Testing Predict Vitiligo?
Researchers have developed polygenic risk scores that combine the 50 known genetic variants into a single number estimating someone’s vitiligo risk. These scores provide a reasonably good assessment of genetic susceptibility in research settings, and vitiligo is actually considered one of the better models for this kind of genetic risk scoring because it involves fewer total genes with relatively large individual effects compared to many other complex diseases. However, polygenic risk scores for vitiligo are not currently used in routine clinical care. The 23% twin concordance rate is a reminder that even a high genetic risk score doesn’t mean someone will develop the condition, and a low score doesn’t guarantee they won’t. No standard genetic test is recommended for families trying to predict whether a child will develop vitiligo.